Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 11;11(1):e002130.
doi: 10.1136/bmjresp-2023-002130.

Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost

David Singer  1 , Philippe Thompson-Leduc  2 , Siyu Ma  3 , Deepshekhar Gupta  4 , Wendy Y Cheng  5 , Aruna Muthukumar  4 , Francesca Devine  6 , Manasvi Sundar  7 , Michael Bogart  8   9 , Ella Hagopian  5 , Sara Poston  10 , Mei Sheng Duh  5 , John J Oppenheimer  11
Affiliations

Herpes zoster burden in patients with asthma: real-world incidence, healthcare resource utilisation and cost

David Singer et al. BMJ Open Respir Res. .

Abstract

Background: Herpes zoster (HZ) is a painful condition caused by reactivation of the varicella-zoster virus. The objectives of this study were to compare HZ incidence in adults with asthma versus adults without asthma and to compare healthcare resource use as well as direct costs in adults with HZ and asthma versus adults with asthma alone in the USA.

Methods: This retrospective longitudinal cohort study included adults aged ≥18 years across the USA. Patients were identified from Optum's deidentified Clinformatics Data Mart Database, an administrative claims database, between 1 October 2015 and 28 February 2020, including commercially insured and Medicare Advantage with part D beneficiaries. Cohorts of patients with and without asthma, and separate cohorts of patients with asthma and HZ and with asthma but not HZ, were identified using International Classification of Diseases 10th Revision, Clinical Modification codes. HZ incidence, healthcare resource use and costs were compared, adjusting for baseline characteristics, between the relevant cohorts using generalised linear models.

Results: HZ incidence was higher in patients with asthma (11.59 per 1000 person-years) than patients without asthma (7.16 per 1000 person-years). The adjusted incidence rate ratio (aIRR) for HZ in patients with asthma, compared with patients without asthma, was 1.34 (95% CI 1.32 to 1.37). Over 12 months of follow-up, patients with asthma and HZ had more inpatient stays (aIRR 1.11; 95% CI 1.02 to 1.21), emergency department visits (aIRR 1.26; 95% CI 1.18 to 1.34) and outpatient visits (aIRR 1.19; 95% CI 1.16 to 1.22), and direct healthcare costs that were US dollars ($) 3058 (95% CI $1671 to $4492) higher than patients with asthma without HZ.

Conclusion: Patients with asthma had a higher incidence of HZ than those without asthma, and among patients with asthma HZ added to their healthcare resource use and costs.

Keywords: Asthma; Asthma Epidemiology; Health Economist; Viral infection.

PubMed Disclaimer

Conflict of interest statement

Competing interests: DS and SP are employed by and hold shares in GSK. PT-L, DG, WYC, AM, FD, MS, EH and MSD are/were employees of Analysis Group, Inc., a consulting firm that received funding from GSK for the conduct of this study. SM declares a postdoctoral fellowship grant from GSK for the conduct of this study. MB was employed by and held shares in GSK at the time of the study. JO received consulting fees for adjudication committees, data and safety monitoring boards or study design from GSK, AstraZeneca, Amgen, Sanofi, and Regeneron, Aquestive Therapeutics, and Aimmune; is a member of the advocacy council of the American Board of Internal Medicine and a member of the American Board of Allergy and Immunology; is a reviewer for UpToDate; and was Executive-Editor of Annals of Allergy, Asthma & Immunology.

Figures

Figure 1
Figure 1
Crude incidence rate and adjusted incidence rate ratio (aIRR) for HZ in cohorts with and without asthma. aIRR, adjusted incidence rate ratio; HZ, herpes zoster.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Vaccination Strategies in Respiratory Diseases: Recommendation from AIPO-ITS/ETS, SIMIT, SIP/IRS, and SItI.
    Micheletto C, Aliberti S, Andreoni M, Blasi F, Di Marco F, Di Matteo R, Gabutti G, Harari S, Gentile I, Parrella R, Siliquini R, Sticchi L; Associazione Italiana Pneumologi Ospedalieri - Italian Thoracic Society (AIPO-ITS/ETS); Società Italiana di Malattie Infettive e Tropicali (SIMIT); Società Italiana di Pneumologia/Italian Respiratory Society (SIP/IRS); Società Italiana di Igiene; Medicina Preventiva e Sanità Pubblica (SItI). Micheletto C, et al. Respiration. 2025;104(8):556-574. doi: 10.1159/000544919. Epub 2025 Mar 9. Respiration. 2025. PMID: 40058339 Free PMC article. Review.

References

    1. Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc 2009;84:274–80. 10.4065/84.3.274 - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Shingles. Clinical overview. 2020. Available: https://www.cdc.gov/shingles/hcp/clinical-overview.html [Accessed 1 Dec 2022].
    1. Van Oorschot D, McGirr A, Goulet P, et al. . A cross-sectional concept elicitation study to understand the impact of herpes zoster on patients' health-related quality of life. Infect Dis Ther 2022;11:501–16. 10.1007/s40121-021-00581-w - DOI - PMC - PubMed
    1. Johnson RW, Bouhassira D, Kassianos G, et al. . The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010;8:37. 10.1186/1741-7015-8-37 - DOI - PMC - PubMed
    1. Dooling KL, Guo A, Patel M, et al. . Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep 2018;67:103–8. 10.15585/mmwr.mm6703a5 - DOI - PMC - PubMed

MeSH terms